BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36798672)

  • 1. FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
    Behnke A; Cayre A; De Maglio G; Giannini G; Habran L; Tarsitano M; Chetta M; Cappellen D; Lespagnol A; Le Naoures C; Massazza G; Destro A; Bonzheim I; Rau A; Battmann A; Kah B; Watkin E; Hummel M
    Pathol Oncol Res; 2023; 29():1610707. PubMed ID: 36798672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
    Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
    Delgado-García M; Weynand B; Gómez-Izquierdo L; Hernández MJ; Blanco ÁM; Varela M; Matias-Guiu X; Nadal E; Márquez-Lobo B; Alarcão A; de Álava E; Biscuola M
    BMC Cancer; 2020 Apr; 20(1):275. PubMed ID: 32245434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
    Colling R; Bancroft H; Langman G; Soilleux E
    Virchows Arch; 2019 Feb; 474(2):187-192. PubMed ID: 30470932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples.
    Offerman S; Prinsen CF; Knol A; Methorst N; Kamphorst J; Niemantsverdriet M
    Diagn Pathol; 2021 Aug; 16(1):70. PubMed ID: 34344387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
    O'Donnell P; Ferguson J; Shyu J; Current R; Rehage T; Tsai J; Christensen M; Tran HB; Chien SS; Shieh F; Wei W; Lawrence HJ; Wu L; Schilling R; Bloom K; Maltzman W; Anderson S; Soviero S
    BMC Cancer; 2013 Apr; 13():210. PubMed ID: 23621958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR Mutation Analysis in Non-small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR System.
    Heeke S; Hofman P
    Methods Mol Biol; 2019; 2054():147-155. PubMed ID: 31482454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
    Thomas De Montpréville V; Ghigna MR; Lacroix L; Lemoine A; Besse B; Mercier O; Fadel É; Dorfmuller P; Le Chevalier T;
    Pathol Res Pract; 2017 Jul; 213(7):793-798. PubMed ID: 28554746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
    Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
    J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility analysis of rapid gene detection using intraoperative frozen tissues: comparison of intraoperative frozen tissues with paraffin-embedded tissues in epidermal growth factor receptor gene mutation detection of lung adenocarcinoma.
    Zhang JJ; Long ZB; Luo LL; Li LH; Yang H; Cao Y; Wang L; Wang WP
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12025-12032. PubMed ID: 37421459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid
    Al-Turkmani MR; Suriawinata MA; Deharvengt SJ; Green DC; Black CC; Shirai K; Dragnev KH; Tsongalis GJ
    Pract Lab Med; 2020 May; 20():e00156. PubMed ID: 32181314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.
    Sousa AC; Silveira C; Janeiro A; Malveiro S; Oliveira AR; Felizardo M; Nogueira F; Teixeira E; Martins J; Carmo-Fonseca M
    Lung Cancer; 2020 Jan; 139():35-40. PubMed ID: 31715539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance Characteristics of a Real-Time Polymerase Chain Reaction Assay for the Detection of Epidermal Growth Factor Receptor (EGFR) Mutations in Plasma Samples of Non-Small Cell Lung Cancer (NSCLC) Patients.
    O'Donnell P; May T; DeMartin K; Ferguson J; Halait H; Wei W; Yu K; Scudder S
    Mol Diagn Ther; 2020 Aug; 24(4):451-460. PubMed ID: 32406048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare epidermal growth factor receptor (EGFR) gene mutation in small cell lung carcinoma patients.
    Hwang CC; Hsieh TY; Yeh KY; Chen TP; Hua CC; Chang LC; Chen JR
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):274-279. PubMed ID: 35228756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer.
    Sakamoto T; Kodani M; Takata M; Chikumi H; Nakamoto M; Nishii-Ito S; Ueda Y; Izumi H; Makino H; Touge H; Takeda K; Yamasaki A; Yanai M; Tanaka N; Igishi T; Shimizu E
    Int J Oncol; 2015 Apr; 46(4):1473-80. PubMed ID: 25651992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidics-based EGFR mutation detection and its implication in the resource-limited clinical setting.
    Joshi P; Gogte P; Pai T; Gurav M; Dhanawade D; Karnik N; Deshpande G; Kaushal R; Shetty O
    Int J Exp Pathol; 2024 Jun; 105(3):90-99. PubMed ID: 38717047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
    Solassol J; Vendrell J; Märkl B; Haas C; Bellosillo B; Montagut C; Smith M; O'Sullivan B; D'Haene N; Le Mercier M; Grauslund M; Melchior LC; Burt E; Cotter F; Stieber D; Schmitt FL; Motta V; Lauricella C; Colling R; Soilleux E; Fassan M; Mescoli C; Collin C; Pagès JC; Sillekens P
    PLoS One; 2016; 11(9):e0163444. PubMed ID: 27685259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.
    Thress KS; Brant R; Carr TH; Dearden S; Jenkins S; Brown H; Hammett T; Cantarini M; Barrett JC
    Lung Cancer; 2015 Dec; 90(3):509-15. PubMed ID: 26494259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas
    Satouchi M; Tanaka H; Yoshioka H; Shimokawaji T; Mizuno K; Takeda K; Yoshino I; Seto T; Kurata T; Tashiro N; Hagiwara K
    Lung Cancer; 2017 Sep; 111():190-194. PubMed ID: 28838392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.
    Nakamura H; Koizumi H; Sakai H; Kimura H; Miyazawa T; Marushima H; Saji H; Takagi M
    Clin Lung Cancer; 2018 Mar; 19(2):170-174. PubMed ID: 29150249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.